Graphical abstract from Long-acting amylin-related peptides as therapies for obesity and type 2 diabetes, by Bailey, Flatt, and Conlon, licensed under CC BY 4.0 Subscribe by email to follow the accumulating evidence and observations that shape our view of health, obesity, and policy.
Retatrutides safety profile is consistent with whats already been observed GLP-1 receptor agonists and combined GLP-1/GIP receptor agonists, meaning the expected side effects are primarily gastrointestinal (GI) in nature: Nausea, vomiting, diarrhea, and constipation
In this context, nootropics come to the forefront - substances that are designed to improve cognitive functions such as memory, concentration, creativity or motivation, without significant side effects
Headache response was based on pain intensity as interpreted by the patient using a four-point pain intensity scale
Yes, prolonged exposure to UV light can also contribute to peptide degradation
We believe in empowering our patients with knowledge and offering thoughtful, comprehensive care